The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Open accessAbstract
Primary liver cancers, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, are leading causes of cancer-related death worldwide. Recent large-scale genomic approaches have identified a wide number of genes whose deregulation is associated with hepatocellular carcinoma and intrahepatic cholangiocarcinoma development. Murine models are critical tools to determine the oncogenic potential of these genes. Conventionally, transgenic or knockout mouse models are used for this purpose. However, several limitations apply to the latter models. Herein, we review a novel approach for stable gene expression in mouse hepatocytes by hydrodynamic injection in combination with Sleeping Beauty-mediated somatic integration. This method represents a flexible, reliable, and cost-effective tool to generate preclinical murine models for liver cancer research. Furthermore, it can be used as an in vivo transfection method to study biochemical cross talks among multiple pathways along hepatocarcinogenesis and to test the therapeutic potential of drugs against liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Ivics, Z., Hackett, P. B., Plasterk, R. H., & Izsvák, Z. (1997) · Cell · doi:10.1016/s0092-8674(00)80436-5 · Cited by 1,430
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Effect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lübbert, H., & Bujard, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10933 · Cited by 778
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Chiba, T., Kita, K., Zheng, Y.-W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H., & Taniguchi, H. (2006) · Hepatology · doi:10.1002/hep.21227 · Cited by 664
Hepatocellular Carcinoma: An Epidemiologic View
El-Serag, H. B. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200211002-00002 · Cited by 633
Calvisi, D. F., Wang, C., Ho, C., Ladu, S., Lee, S. A., Mattu, S., Destefanis, G., Delogu, S., Zimmermann, A., Ericsson, J., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.006 · Cited by 595
Self-citationCholangiocarcinomas can originate from hepatocytes in mice
Fan, B., Malato, Y., Calvisi, D. F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G. J., Dombrowski, F., Evert, M., Chen, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63212 · Cited by 529
Self-citation(2003) · PubMed · Cited by 523
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Cairo, S., Armengol, C., De Reyniès, A., Wei, Y., Thomas, E., Renard, C.-A., Goga, A., Balakrishnan, A., Semeraro, M., Gresh, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.002 · Cited by 509
Yant, S. R., Meuse, L., Chiu, W., Ivics, Z., Izsvak, Z., & Kay, M. A. (2000) · Nature Genetics · doi:10.1038/75568 · Cited by 509
WNT/β‐catenin signaling in liver health and disease
Thompson, M. D., & Monga, S. P. S. (2007) · Hepatology · doi:10.1002/hep.21651 · Cited by 471
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Asokan, A., Schaffer, D. V., & Jude Samulski, R. (2012) · Molecular Therapy · doi:10.1038/mt.2011.287 · Cited by 465
Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling
Mason, J. M., Morrison, D. J., Albert Basson, M., & Licht, J. D. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.11.004 · Cited by 424
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Lee, J.-S., Conner, E. A., Schroeder, I., Factor, V. M., & Thorgeirsson, S. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31457 · Cited by 393
Self-citationExperimental mouse models for hepatocellular carcinoma research
Heindryckx, F., Colle, I., & Van Vlierberghe, H. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00656.x · Cited by 367
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
Yang, B., Guo, M., Herman, J. G., & Clark, D. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63469-4 · Cited by 365
Grompe, M., al-Dhalimy, M., Finegold, M., Ou, C. N., Burlingame, T., Kennaway, N. G., & Soriano, P. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2298 · Cited by 355 · cited 1×
“Loss of the Fah (fumaryl-acetoacetate hydrolase) gene leads to neonatal death due to liver failure.(53) The lethality can be rescued by feeding the mice with nitisinone (NTBC), a drug that inhibits the upstream enzyme, 4-hydrozyphenylpyruvate diogenease, in the tyrosine metabolism pathway.”
BackgroundContributions of Human Tumor Xenografts to Anticancer Drug Development
Sausville, E. A., & Burger, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3627 · Cited by 348
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Sekiya, S., & Suzuki, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63065 · Cited by 348
Siddique, H. R., & Saleem, M. (2012) · STEM CELLS · doi:10.1002/stem.1035 · Cited by 339
Cholangiocarcinoma—controversies and challenges
Patel, T. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.20 · Cited by 337
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333
Hydroporation as the mechanism of hydrodynamic delivery
Zhang, G., Gao, X., Song, Y. K., Vollmer, R., Stolz, D. B., Gasiorowski, J. Z., Dean, D. A., & Liu, D. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302210 · Cited by 331
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J.-H., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 330
Genetics of hepatocellular carcinoma
Annick Buendia, M. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0319 · Cited by 329
Epidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
Efficient lentiviral transduction of liver requires cell cycling in vivo
Park, F., Ohashi, K., Chiu, W., Naldini, L., & Kay, M. A. (2000) · Nature Genetics · doi:10.1038/71673 · Cited by 323
Orthotopic models of cancer for preclinical drug evaluation
Bibby, M. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.021 · Cited by 315
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T., & Kurokawa, K. (1994) · Hepatology · doi:10.1002/hep.1840190403 · Cited by 287
Shim, K., Minowada, G., Coling, D. E., & Martin, G. R. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.009 · Cited by 246
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
Sia, D., Tovar, V, Moeini, A., & Llovet, J. M. (2013) · Oncogene · doi:10.1038/onc.2012.617 · Cited by 235
Ho, C., Wang, C., Mattu, S., Destefanis, G., Ladu, S., Delogu, S., Armbruster, J., Fan, L., Lee, S. A., Jiang, L., et al. (2012) · Hepatology · doi:10.1002/hep.24736 · Cited by 233
Self-citationSorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Kane, R. C., Farrell, A. T., Madabushi, R., Booth, B., Chattopadhyay, S., Sridhara, R., Justice, R., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0185 · Cited by 221
Distinct pathways of genomic progression to benign and malignant tumors of the liver
Tward, A. D., Jones, K. D., Yant, S., Cheung, S. T., Fan, S. T., Chen, X., Kay, M. A., Wang, R., & Bishop, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706578104 · Cited by 217
Self-citationTargeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
Zhou, Q., Lui, V. W., & Yeo, W. (2011) · Future Oncology · doi:10.2217/fon.11.95 · Cited by 210
Xu, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27282 · Cited by 207
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Zender, S., Nickeleit, I., Wuestefeld, T., Sörensen, I., Dauch, D., Bozko, P., El-Khatib, M., Geffers, R., Bektas, H., Manns, M. P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.019 · Cited by 200
Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
Harada, N., Oshima, H., Katoh, M., Tamai, Y., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2123 · Cited by 194
Chiba, T., Miyagi, S., Saraya, A., Aoki, R., Seki, A., Morita, Y., Yonemitsu, Y., Yokosuka, O., Taniguchi, H., Nakauchi, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5882 · Cited by 194
Cancer gene discovery in hepatocellular carcinoma
Zender, L., Villanueva, A., Tovar, V., Sia, D., Chiang, D. Y., & Llovet, J. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.034 · Cited by 186
Bakiri, L., & Wagner, E. F. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.01.005 · Cited by 172
Lo, T. L., Yusoff, P., Fong, C. W., Guo, K., McCaw, B. J., Phillips, W. A., Yang, H., Wong, E. S. M., Leong, H. F., Zeng, Q., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1207 · Cited by 171
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cadoret, A., Ovejero, C., Saadi-Kheddouci, S., Souil, E., Fabrè, M., Romagnolo, B., Kahn, A., & Perret, C. (2001) · PubMed · Cited by 169
Bunting, K. D., Zhou, S., Lu, T., & Sorrentino, B. P. (2000) · Blood · doi:10.1182/blood.v96.3.902 · Cited by 168
Genetics of Hepatobiliary Carcinogenesis
Nault, J., & Zucman‐Rossi, J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1276646 · Cited by 167
Fong, C. W., Chua, M., McKie, A. B., Ling, S. H. M., Mason, V., Li, R., Yusoff, P., Lo, T. L., Leung, H. Y., So, S. K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1072 · Cited by 150
A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration
Wuestefeld, T., Pesic, M., Rudalska, R., Dauch, D., Longerich, T., Kang, T.-W., Yevsa, T., Heinzmann, F., Hoenicke, L., Hohmeyer, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.026 · Cited by 149
Mikkelsen, J. G., Yant, S. R., Meuse, L., Huang, Z., Xu, H., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00216-8 · Cited by 149
In Vivo Correction of Murine Tyrosinemia Type I by DNA-Mediated Transposition
Montini, E., Held, P. K., Noll, M., Morcinek, N., Al-Dhalimy, M., Finegold, M. J., Yant, S. R., Kay, M. A., & Grompe, M. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0812 · Cited by 142
Carlson, C. M., Frandsen, J. L., Kirchhof, N., McIvor, R. S., & Largaespada, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502974102 · Cited by 134
In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery
Held, P. K., Olivares, E. C., Aguilar, C., Finegold, M. J., Calos, M. P., & Grompe, M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.001 · Cited by 129
Cholangiocarcinoma: Epidemiology, Risk Factors, Pathogenesis, and Diagnosis
Charbel, H., & Al-Kawas, F. H. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0178-8 · Cited by 128
Lee, S. A., Ho, C., Roy, R., Kosinski, C., Patil, M. A., Tward, A. D., Fridlyand, J., & Chen, X. (2008) · Hepatology · doi:10.1002/hep.22169 · Cited by 114
Self-citationRole of Alcohol in Liver Carcinogenesis
McKillop, I. H., & Schrum, L. W. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214377 · Cited by 111
Chen, Q., Seol, D., Carr, B. I., & Zarnegar, R. (1997) · Hepatology · doi:10.1002/hep.510260108 · Cited by 105
Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
Chow, E. K., Fan, L., Chen, X., & Bishop, M. J. (2012) · Hepatology · doi:10.1002/hep.25776 · Cited by 103
Self-citationJeliazkova, P., Jörs, S., Lee, M., Zimber‐Strobl, U., Ferrer, J. P., Schmid, R. M., Siveke, J. T., & Geisler, F. (2013) · Hepatology · doi:10.1002/hep.26254 · Cited by 100
Farazi, P. A., Zeisberg, M., Glickman, J. N., Zhang, Y., Kalluri, R., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4609 · Cited by 99
Fava, G., Marucci, L., Glaser, S. S., Francis, H., Morrow, S. D., Benedetti, A., Alvaro, D., Venter, J. K., Meininger, C. J., Patel, T. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1470 · Cited by 98
Wang, C., Cigliano, A., Delogu, S., Armbruster, J., Dombrowski, F., Evert, M., Chen, X., & Calvisi, D. F. (2013) · Cell Cycle · doi:10.4161/cc.25099 · Cited by 96
Self-citationMouse Models of Hepatocellular Carcinoma
Fausto, N., & Campbell, J. S. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247135 · Cited by 91
Riordan, J. D., Keng, V. W., Tschida, B. R., Scheetz, T. E., Bell, J. B., Podetz-Pedersen, K. M., Moser, C. D., Copeland, N. G., Jenkins, N. A., Roberts, L. R., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003441 · Cited by 91
Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
Stauffer, J. K., Scarzello, A. J., Andersen, J. B., Kluyver, R. L. D., Back, T. C., Weiss, J. M., Thorgeirsson, S. S., & Wiltrout, R. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2705 · Cited by 89
Role of Cyclin D1 as a Mediator of c-Met– and β-Catenin–Induced Hepatocarcinogenesis
Patil, M. A., Lee, S. A., Macias, E., Lam, E. T., Xu, C., Jones, K. D., Ho, C., Rodríguez‐Puebla, M. L., & Chen, X. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2514 · Cited by 89
Self-citationInvolvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
Ozaki, I., Mizuta, T., Zhao, G., Yotsumoto, H., Hara, T., Kajihara, S., Hisatomi, A., Sakai, T., & Yamamoto, K. (2000) · PubMed · Cited by 87
c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella, A., Gramlich, T. L., Fritsch, C., & Gansler, T. S. (1996) · PubMed · Cited by 85
Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis
Xu, C., Lee, S., Ho, C., Bommi, P. V., Huang, S., Cheung, S., Dimri, G. P., & Chen, X. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0333 · Cited by 74
Self-citationKeng, V. W., Tschida, B. R., Bell, J. B., & Largaespada, D. A. (2010) · Hepatology · doi:10.1002/hep.24091 · Cited by 73
Exploring genomic profiles of hepatocellular carcinoma
Woo, H. G., Park, E. S., Thorgeirsson, S. S., & Kim, Y. J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20691 · Cited by 70
Wang, C., Delogu, S., Ho, C., Lee, S. A., Gui, B., Jiang, L., Ladu, S., Cigliano, A., Dombrowski, F., Evert, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.026 · Cited by 64
Self-citationLee, S. A., Ladu, S., Evert, M., Dombrowski, F., Murtas, V. D., Chen, X., & Calvisi, D. F. (2010) · Hepatology · doi:10.1002/hep.23681 · Cited by 60
Self-citationA facile method for somatic, lifelong manipulation of multiple genes in the mouse liver
Wangensteen, K. J., Wilber, A. C., Keng, V. W., He, Z., Matise, I., Wangensteen, L., Carson, C. M., Chen, Y., Steer, C. J., McIvor, S. R., et al. (2008) · Hepatology · doi:10.1002/hep.22195 · Cited by 59
Breuhahn, K., Gores, G. J., & Schirmacher, P. (2011) · Hepatology · doi:10.1002/hep.24313 · Cited by 53
Molecular pathology of biliary tract cancers
Fava, G., Marzioni, M., Benedetti, A., Glaser, S. S., DeMorrow, S., Francis, H., & Alpini, G. D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.09.011 · Cited by 52
Ju, H.-L., Ahn, S. H., Kim, D. Y., Baek, S., Chung, S. I., Seong, J., Han, K., & Ro, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059869 · Cited by 51
Gürlevik, E., Fleischmann-Mundt, B., Armbrecht, N., Longerich, T., Woller, N., Kloos, A., Hoffmann, D., Schambach, A., Wirth, T. C., Manns, M. P., et al. (2013) · Hepatology · doi:10.1002/hep.26468 · Cited by 39
Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development
Fan, L., Xu, C., Wang, C., Tao, J., Ho, C., Jiang, L., Gui, B., Huang, S., Evert, M., Calvisi, D. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046472 · Cited by 37
Self-citationAAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?
van der Laan, L. J. W., Wang, Y., Tilanus, H. W., Janssen, H. L. A., & Pan, Q. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.548799 · Cited by 32
Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma
Braconi, C., Swenson, E. A., Kogure, T., Huang, N., & Patel, T. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015195 · Cited by 31
Priming of Hepatocytes Enhances In Vivo Liver Transduction with Lentiviral Vectors in Adult Mice
Pichard, V., Boni, S., Baron, W., Nguyen, T. H., & Ferry, N. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2011.010 · Cited by 16
On the role of notch1 and adult hepatocytes in murine intrahepatic cholangiocarcinoma development
Evert, M., Dombrowski, F., Fan, B., Ribback, S., Chen, X., & Calvisi, D. F. (2013) · Hepatology · doi:10.1002/hep.26411 · Cited by 12
Self-citation
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationRuiz de Galarreta, M., Bresnahan, E., Molina-Sánchez, P., Lindblad, K. E., Maier, B., Sia, D., Puigvehi, M., Miguela, V., Casanova-Acebes, M., Dhainaut, M., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0074 · Cited by 912
MET is required for the recruitment of anti-tumoural neutrophils
Finisguerra, V., Di Conza, G., Di Matteo, M., Serneels, J., Costa, S., Thompson, A. A. R., Wauters, E., Walmsley, S., Prenen, H., Granot, Z., et al. (2015) · Nature · doi:10.1038/nature14407 · Cited by 492
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Moon, S.-H., Huang, C.-H., Houlihan, S. L., Regunath, K., Freed-Pastor, W. A., Morris, J. P., Tschaharganeh, D. F., Kastenhuber, E. R., Barsotti, A. M., Culp-Hill, R., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.011 · Cited by 435
A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis
Yao, F., Deng, Y., Zhao, Y., Mei, Y., Zhang, Y., Liu, X., Martinez, C., Su, X., Rosato, R. R., Teng, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27452-9 · Cited by 322
Self-citation
Metadata
- Authors
- Chen, X., & Calvisi, D. F.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 184
- Issue
- 4
- Pages
- 912-923
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2087106096
- Cited by
- 434
- References
- 102
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.